Literature DB >> 32819564

Cofilin 1 promotes the aggregation and cell-to-cell transmission of α-synuclein in Parkinson's disease.

Mingmin Yan1, Lanxia Meng2, Lijun Dai2, Xingyu Zhang2, Guiqin Chen3, Yongfa Zheng4, Yunhong Zha5, Yan Zeng6, Zhentao Zhang7.   

Abstract

The histopathological hallmark of Parkinson's disease (PD) is the presence of fibrillar aggregates referred to as Lewy bodies (LBs), in which α-synuclein is the major component. Converging evidence supports the prion-like transmission of α-synuclein aggregates in the onset and progression of PD. Intracellular α-synuclein aggregates into pathological fibrils, which can be transferred from aggregate-producing cells to aggregate-free cells, triggering neuronal injury and the progression of pathology. However, the specific mechanisms mediating the aggregation and transmission of pathological α-synuclein remain unknown. Here we show that cofilin 1 binds to α-synuclein and promotes its aggregation. The mixed fibrils consist of cofilin 1 and α-synuclein are more compact and more potent than pure α-synuclein fibrils in seeding α-synuclein aggregation. Cofilin 1 also facilitates the uptake of α-synuclein fibrils and finally induces neuronal dysfunction. Together, these observations indicate that cofilin 1 acts as a crucial mediator in the aggregation and propagation of pathological α-synuclein, contributing to the pathogenesis of PD.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aggregation; Cofilin 1; Seeds; Transmission; α-Synuclein

Year:  2020        PMID: 32819564     DOI: 10.1016/j.bbrc.2020.06.101

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Cofilin 1 promotes the pathogenicity and transmission of pathological α-synuclein in mouse models of Parkinson's disease.

Authors:  Mingmin Yan; Min Xiong; Lijun Dai; Xingyu Zhang; Yunhong Zha; Xiaorong Deng; Zhui Yu; Zhentao Zhang
Journal:  NPJ Parkinsons Dis       Date:  2022-01-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.